| Entry |
|
|---|
| Name |
Phentermine and topiramate;
Qsymia (TN) |
|---|
| Product |
|
|---|
| Component |
|
|---|
| Class |
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiobesity |
|---|
| Comment |
Phentermine is metabolized by CYP3A4.
|
|---|
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08AA Centrally acting antiobesity products
A08AA51 Phentermine and topiramate
D11710 Phentermine and topiramate <US>
USP drug classification [BR:br08302]
Anti-Obesity Agents
Phentermine Hydrochloride/ Topiramate
D11710 Phentermine and topiramate
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D11710 Phentermine and topiramate
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11710
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
